IVCR.Q Stock Overview
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Invacare Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.013 |
52 Week High | US$1.64 |
52 Week Low | US$0.011 |
Beta | 0.51 |
1 Month Change | -10.00% |
3 Month Change | -62.60% |
1 Year Change | -99.09% |
3 Year Change | -99.77% |
5 Year Change | -99.92% |
Change since IPO | -99.49% |
Recent News & Updates
Recent updates
Invacare falls on bankruptcy filing
Feb 01Invacare announces additional draw of $5.5M term loans
Dec 27Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates
Nov 14Invacare GAAP EPS of -$0.92, revenue of $170.4M
Nov 07Invacare receives non-compliance letter from NYSE
Sep 29Invacare names Geoffrey Purtill as interim president and executive chief
Aug 29Invacare adds two new directors after deal with largest investor Azurite
Aug 23Returns Are Gaining Momentum At Invacare (NYSE:IVC)
Apr 30Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky
Jan 27Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
Dec 01Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load
Sep 30When Should You Buy Invacare Corporation (NYSE:IVC)?
Aug 06Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)
May 14Invacare EPS misses by $0.02, misses on revenue
May 05Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
May 03Invacare Corporation's (NYSE:IVC) Path To Profitability
Mar 03Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet
Feb 05What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?
Jan 10Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.
Dec 14Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit
Nov 23Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation
Oct 30Shareholder Returns
IVCR.Q | US Medical Equipment | US Market | |
---|---|---|---|
7D | -10.6% | -1.5% | -2.4% |
1Y | -99.1% | 10.0% | 23.4% |
Return vs Industry: IVCR.Q underperformed the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: IVCR.Q underperformed the US Market which returned 15.2% over the past year.
Price Volatility
IVCR.Q volatility | |
---|---|
IVCR.Q Average Weekly Movement | 28.2% |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: IVCR.Q's share price has been volatile over the past 3 months.
Volatility Over Time: IVCR.Q's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1885 | 2,800 | Geoff Purtill | www.invacare.com |
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the Pin Dot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products.
Invacare Corporation Fundamentals Summary
IVCR.Q fundamental statistics | |
---|---|
Market cap | US$512.81k |
Earnings (TTM) | -US$101.07m |
Revenue (TTM) | US$741.73m |
0.0x
P/S Ratio0.0x
P/E RatioIs IVCR.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IVCR.Q income statement (TTM) | |
---|---|
Revenue | US$741.73m |
Cost of Revenue | US$557.69m |
Gross Profit | US$184.04m |
Other Expenses | US$285.12m |
Earnings | -US$101.07m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -2.66 |
Gross Margin | 24.81% |
Net Profit Margin | -13.63% |
Debt/Equity Ratio | 436.8% |
How did IVCR.Q perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/05/05 01:52 |
End of Day Share Price | 2023/05/05 00:00 |
Earnings | 2022/12/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Invacare Corporation is covered by 9 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Labick | CJS Securities, Inc. |
Constantine Davides | D. Boral Capital LLC. |
Matthew Mishan | KeyBanc Capital Markets Inc. |